Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms

Peer Review reports

Original Submission
28 Jul 2015	Submitted	Original manuscript
1 Sep 2015	Reviewed	Reviewer Report - Samuel Klempner
21 Dec 2015	Reviewed	Reviewer Report - Nerissa Viola-Villegas
30 Dec 2015	Reviewed	Reviewer Report - Joseph Chao
6 Jan 2016	Author responded	Author comments - Kimihiro Ito
Resubmission - Version 2
6 Jan 2016	Submitted	Manuscript version 2
Publishing
19 Jan 2016	Editorially accepted
25 Jan 2016	Article published	10.1186/s12885-016-2072-0

Back to article page